Related Experiment Videos
Sequential fine needle aspiration biopsy in glomerulonephritis.
The International Journal of Pediatric Nephrology
|January 1, 1986
Summary
Monitoring cellular immune responses with Fine Needle Aspiration Biopsy (FNAB) helps guide glomerulonephritis treatment. Targeted immunosuppression, including methylprednisolone pulses, improved patient outcomes effectively.
Area of Science:
- Nephrology
- Immunology
- Cellular Biology
Background:
- Cellular immune mechanisms are critical in glomerulonephritis pathogenesis.
- Inflammatory mediators contribute to glomerular and tubular injury.
- Understanding these pathways enables therapeutic interventions.
Purpose of the Study:
- To correlate peripheral blood immunological findings with renal tissue infiltrate composition.
- To assess clinical status and monitor immunosuppressive therapy using weekly Fine Needle Aspiration Biopsy (FNAB).
Main Methods:
- Utilized Total Corrected Increment (T.C.I.) to quantify inflammation intensity.
- Employed the OKT4/OKT8 ratio as an index for immunologic activation.
- Implemented a treatment strategy based on T.C.I. and OKT4/OKT8 ratio thresholds.
Main Results:
- Standard treatment alone showed variable outcomes.
- Spontaneous improvement occurred in some untreated patients.
- Standard therapy combined with methylprednisolone pulses led to progressive clinical improvement in all treated patients.
Conclusions:
- FNAB is a valuable tool for monitoring immune status in glomerulonephritis.
- Aggressive immunosuppression with methylprednisolone pulses is effective for severe cases.
- Personalized treatment based on immune monitoring improves glomerulonephritis prognosis.